• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清对人类免疫缺陷病毒(HIV)感染的增强作用与HIV感染者的疾病相关。

Serum enhancement of human immunodeficiency virus (HIV) infection correlates with disease in HIV-infected individuals.

作者信息

Homsy J, Meyer M, Levy J A

机构信息

Department of Medicine, School of Medicine, University of California, San Francisco 94143-0128.

出版信息

J Virol. 1990 Apr;64(4):1437-40. doi: 10.1128/JVI.64.4.1437-1440.1990.

DOI:10.1128/JVI.64.4.1437-1440.1990
PMID:2319642
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC249276/
Abstract

The sera from 16 individuals infected with the human immunodeficiency virus (HIV) at different clinical stages were evaluated for antibody-dependent neutralization and/or enhancement of infectivity by HIV. The HIV isolate from each individual (homotypic) and established laboratory strains showing broad cellular host range and cytopathicity were used. All sera could neutralize one of the laboratory-passaged isolates, whereas only two could neutralize the corresponding homotypic strain. Seven homotypic isolates were enhanced by serum from the respective individual. This activity was primarily observed in patients with acquired immune deficiency syndrome. Moreover, the tropism for macrophages of four of these seven viral isolates was found to be enhanced by the homotypic sera. Finally, sequential pairs of HIV and sera obtained from five HIV-infected individuals with different clinical progression were studied over time. The enhancing activity of three of the five sera appeared to increase over time, indicating changes in both the host virus population and the type of antibodies produced. These results suggest that enhancing antibodies contribute to the spread and pathogenesis of HIV in vivo. They emphasize the necessity of studying further the association of enhancing antibodies and disease progression in infected individuals.

摘要

对16名处于不同临床阶段的人类免疫缺陷病毒(HIV)感染者的血清进行了评估,以检测其对HIV的抗体依赖性中和作用和/或感染性增强作用。使用了来自每个个体的HIV分离株(同型)以及具有广泛细胞宿主范围和细胞病变效应的既定实验室菌株。所有血清都能中和一种实验室传代分离株,而只有两份血清能中和相应的同型菌株。七种同型分离株被各自个体的血清增强了感染性。这种活性主要在获得性免疫缺陷综合征患者中观察到。此外,发现这七种病毒分离株中的四种对巨噬细胞的嗜性被同型血清增强。最后,对五名具有不同临床进展的HIV感染者随时间获取的HIV和血清序列对进行了研究。五份血清中的三份的增强活性似乎随时间增加,表明宿主病毒群体和产生的抗体类型都发生了变化。这些结果表明,增强性抗体在体内促进了HIV的传播和发病机制。它们强调了进一步研究感染个体中增强性抗体与疾病进展之间关联的必要性。

相似文献

1
Serum enhancement of human immunodeficiency virus (HIV) infection correlates with disease in HIV-infected individuals.血清对人类免疫缺陷病毒(HIV)感染的增强作用与HIV感染者的疾病相关。
J Virol. 1990 Apr;64(4):1437-40. doi: 10.1128/JVI.64.4.1437-1440.1990.
2
Neutralization of multiple HIV-1 isolates from a single subject by autologous sequential sera.同一受试者的自体序贯血清对多种HIV-1分离株的中和作用。
J Infect Dis. 1990 Sep;162(3):735-7. doi: 10.1093/infdis/162.3.735.
3
Homotypic antibody responses to fresh clinical isolates of human immunodeficiency virus.针对人类免疫缺陷病毒新鲜临床分离株的同型抗体反应。
Virology. 1991 Jun;182(2):635-43. doi: 10.1016/0042-6822(91)90604-a.
4
Analysis of neutralizing and enhancing antibodies to human immunodeficiency virus type 1 primary isolates in plasma of individuals infected with env Genetic subtype B and E viruses in Thailand.泰国感染env基因B亚型和E亚型病毒的个体血浆中针对1型人类免疫缺陷病毒原始分离株的中和抗体和增强抗体分析。
Viral Immunol. 1996;9(3):175-85. doi: 10.1089/vim.1996.9.175.
5
Human immunodeficiency virus (HIV)-positive sera obtained shortly after seroconversion neutralize autologous HIV type 1 isolates on primary macrophages but not on lymphocytes.在血清转化后不久获得的人类免疫缺陷病毒(HIV)阳性血清可中和原代巨噬细胞上的自体1型HIV分离株,但不能中和淋巴细胞上的该分离株。
J Virol. 2000 Jun;74(12):5403-11. doi: 10.1128/jvi.74.12.5403-5411.2000.
6
Absence of a clinical correlation for complement-mediated, infection-enhancing antibodies in plasma or sera from HIV-1-infected individuals. Multicenter AIDS Cohort Study Group.来自HIV-1感染者的血浆或血清中补体介导的感染增强抗体缺乏临床相关性。多中心艾滋病队列研究组。
AIDS. 1991 May;5(5):513-7. doi: 10.1097/00002030-199105000-00006.
7
Neutralizing and complement-dependent enhancing antibodies in different stages of HIV infection.
AIDS. 1991 Mar;5(3):263-8. doi: 10.1097/00002030-199103000-00003.
8
Neutralizing and enhancing antibodies measured in complement-restored serum samples from HIV-1-infected individuals correlate with immunosuppression and disease.
AIDS. 1994 May;8(5):603-9. doi: 10.1097/00002030-199405000-00005.
9
HIV-1MN recombinant gp120 vaccine serum, which fails to neutralize primary isolates of HIV-1, does not antagonize neutralization by antibodies from infected individuals.无法中和HIV-1原始分离株的HIV-1MN重组gp120疫苗血清,不会拮抗来自受感染个体的抗体的中和作用。
AIDS. 1994 Nov;8(11):1622-3. doi: 10.1097/00002030-199411000-00017.
10
Neutralizing antibodies and serum interferon levels in the different stages of HIV infection.HIV感染不同阶段的中和抗体及血清干扰素水平
Acta Virol. 1990 Apr;34(2):164-70.

引用本文的文献

1
Comprehensive profiling of pre-infection antibodies identifies HIV targets associated with viremic control and viral load.全面分析感染前抗体可鉴定与病毒血症控制和病毒载量相关的 HIV 靶标。
Front Immunol. 2023 Sep 6;14:1178520. doi: 10.3389/fimmu.2023.1178520. eCollection 2023.
2
African Swine Fever Vaccinology: The Biological Challenges from Immunological Perspectives.非洲猪瘟疫苗学:从免疫学角度看生物挑战。
Viruses. 2022 Sep 13;14(9):2021. doi: 10.3390/v14092021.
3
Mucosal AIDS virus transmission is enhanced by antiviral IgG isolated early in infection.黏膜艾滋病病毒传播被早期感染时分离的抗病毒 IgG 增强。
AIDS. 2021 Dec 1;35(15):2423-2432. doi: 10.1097/QAD.0000000000003050.
4
The CD8 T Cell Noncytotoxic Antiviral Responses.CD8 T 细胞非细胞毒性抗病毒反应。
Microbiol Mol Biol Rev. 2021 May 12;85(2). doi: 10.1128/MMBR.00155-20. Print 2021 May 19.
5
Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine Trial.Fc 受体多态性调节 HVTN 505 艾滋病毒疫苗试验中 HIV-1 风险的疫苗效果。
J Virol. 2019 Oct 15;93(21). doi: 10.1128/JVI.02041-18. Print 2019 Nov 1.
6
Antibody-Dependent Cellular Phagocytosis in Antiviral Immune Responses.抗体依赖的细胞吞噬作用在抗病毒免疫反应中的作用。
Front Immunol. 2019 Feb 28;10:332. doi: 10.3389/fimmu.2019.00332. eCollection 2019.
7
Neutralization-Enhancing RF Antibodies for HIV Vaccines.用于HIV疫苗的中和增强型RF抗体。
Front Immunol. 2014 Dec 16;5:634. doi: 10.3389/fimmu.2014.00634. eCollection 2014.
8
Association of Fcγ receptor IIIa genotype with the rate of HIV infection after gp120 vaccination.Fcγ 受体 IIIa 基因型与 gp120 疫苗接种后 HIV 感染率的关系。
Blood. 2012 Oct 4;120(14):2836-42. doi: 10.1182/blood-2012-05-431361. Epub 2012 Aug 22.
9
A weak neutralizing antibody response to hepatitis C virus envelope glycoprotein enhances virus infection.对丙型肝炎病毒包膜糖蛋白的弱中和抗体反应增强了病毒感染。
PLoS One. 2011;6(8):e23699. doi: 10.1371/journal.pone.0023699. Epub 2011 Aug 22.
10
Virus-host interactions in HIV pathogenesis: directions for therapy.HIV发病机制中的病毒-宿主相互作用:治疗方向
Adv Dent Res. 2011 Apr;23(1):13-8. doi: 10.1177/0022034511398874.

本文引用的文献

1
Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes.淋巴结病相关病毒(LAV)对辅助诱导性T淋巴细胞的选择性嗜性。
Science. 1984 Jul 6;225(4657):59-63. doi: 10.1126/science.6328660.
2
Identification of human immunodeficiency virus subtypes with distinct patterns of sensitivity to serum neutralization.对血清中和敏感性具有不同模式的人类免疫缺陷病毒亚型的鉴定。
Proc Natl Acad Sci U S A. 1988 Apr;85(8):2815-9. doi: 10.1073/pnas.85.8.2815.
3
The human immunodeficiency virus: infectivity and mechanisms of pathogenesis.人类免疫缺陷病毒:传染性与发病机制
Science. 1988 Feb 5;239(4840):617-22. doi: 10.1126/science.3277274.
4
The natural history of human immunodeficiency virus infection.人类免疫缺陷病毒感染的自然史。
J Infect Dis. 1988 Dec;158(6):1360-7. doi: 10.1093/infdis/158.6.1360.
5
AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen.艾滋病逆转录病毒诱导的细胞病理学:巨细胞形成与CD4抗原的参与。
Science. 1986 May 30;232(4754):1123-7. doi: 10.1126/science.3010463.
6
Induction of HTLV-III/LAV from a nonvirus-producing T-cell line: implications for latency.从一个不产生病毒的T细胞系中诱导出HTLV-III/LAV:对潜伏感染的意义。
Science. 1986 Feb 7;231(4738):600-2. doi: 10.1126/science.3003906.
7
Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule.人嗜T淋巴细胞病毒III型/淋巴腺病相关病毒通过110K病毒蛋白与T4分子的复合物与T4+ T细胞结合。
Science. 1986 Jan 24;231(4736):382-5. doi: 10.1126/science.3001934.
8
Persistent noncytopathic infection of normal human T lymphocytes with AIDS-associated retrovirus.艾滋病相关逆转录病毒对正常人T淋巴细胞的持续非细胞病变感染。
Science. 1985 Sep 27;229(4720):1400-2. doi: 10.1126/science.2994222.
9
Genomic diversity of the acquired immune deficiency syndrome virus HTLV-III: different viruses exhibit greatest divergence in their envelope genes.获得性免疫缺陷综合征病毒HTLV-III的基因组多样性:不同病毒在其包膜基因中表现出最大差异。
Proc Natl Acad Sci U S A. 1985 Jul;82(14):4813-7. doi: 10.1073/pnas.82.14.4813.
10
Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy-associated virus (LAV).用于检测和定量人类感染性逆转录病毒——淋巴结病相关病毒(LAV)的免疫测定法。
J Immunol Methods. 1985 Jan 21;76(1):171-83. doi: 10.1016/0022-1759(85)90489-2.